The association between epilepsy and erectile dysfunction (ED) has often been described but not clearly defined. This is a review of the literature regarding the current theories on the causes of ED in epilepsy, as well as the evaluation and treatment options available. © 2004 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
The association between epilepsy and erectile dysfunction (ED) has often been described but not clearly defined. Sexual dysfunction as a disorder is complex and often multifactorial, with medical, psychological, and life circumstances all playing important roles. Epileptic men have been found to have an increased risk of ED of up to 57% 1 compared to 3-9% in the general population. 2, 3 There has not been a consensus regarding the prevalence of ED in patients with epilepsy. Studies have indicated that the prevalence of ED varies within particular epileptic patient populations, with the frequency being as low as 3% in outpatient populations 4 to as high as 58% in patients evaluated for epilepsy surgery. 5 There are many sexual disorders that have been described as having a connection with epilepsy, such as self-mutilation and sadomasochism, 6 exhibitionism, 6, 7 and fetishism. 8 The dysfunction most often mentioned by patients includes decreased desire, reduced potency, and impaired sexual performance. However, recent studies have suggested that epilepsy interferes specifically with physiological dysfunction while sexual desire remains unaffected. 9, 10 The most common form of sexual dysfunction that has been described has been *Corresponding author. Tel.: +1-631-444-1910; fax: +1-631-444-7620.
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that of hyposexuality, defined as a global reduction in sexual interest, awareness, and activity. 11 Certain sexual disorders have been associated with specific periods of seizure activity, and fall into two discrete categories: those directly related to the epileptic discharge period (ictal), and those unrelated in time to seizure occurrence (interictal). Hypersexuality has been connected to ictal seizure activity 12, 13 while hyposexuality has been linked to interictal seizure activity. 13, 14 The specific locus of epileptiform discharge leading to erectile dysfunction has also been the subject of scrutiny and debate. It has been postulated that patients with temporal lobe epilepsy (TLE) appear more prone to hypogonadism and sexual abnormality. [14] [15] [16] [17] [18] It has also been established that TLE is more common in men. 19 There have been several studies linking hyposexuality to focal seizures, 14, [20] [21] [22] [23] particularly those with TLE compared to patients with primary generalized epilepsy. Shukla et al. 14 studied 44 adults with TLE, and 47 adults with primary generalized epilepsy. They found that 63% of men and 64% of women with TLE were hyposexual while 12% of men and 8% of women with generalized epilepsy.
Gastaut and Collomb 20 postulated that onset of seizures prior to or during puberty may have a marked effect on the hypothalamic-pituitary axis affecting normal sexual development, attitudes, and behavior. Research supporting this theory found that there were higher levels of gonadotropins in patients with onset of epilepsy prior to the age of 14, 1 and that men whose epilepsy had undergone remission by the age of 12 years were more likely to have normal sexual performance and be more likely to marry. 24 These findings have been disputed in numerous recent studies, 3, 10, 18, 21 all of which found that there was no correlation between the age of onset of epilepsy and sexual dysfunction.
A correlation between hyposexuality and the severity or frequency of seizure episodes has been described. Studies have found increased incidence of erectile dysfunction in times of stress or increased seizure frequency 5, 25, 26 as well as patients being assessed for epilepsy surgery. 6, 8 Additionally, studies found lower rates of hyposexuality in patients with increased duration of seizure freedom, 5, 18 indicating that adequate treatment of epilepsy may lead to an improvement in sexual function. Taylor 6 evaluated 100 patients who had surgical intervention for TLE, pre-and postoperatively. Prior to surgery, 86 had pre-operative evidence of sexual dysfunction. Postoperatively, 14 patients were free of sexual dysfunction, 22 patients showed improved sexual dysfunction, 36 showed no change in sexual function, and 14 patients showed decreased sexual function from their baseline, which at the time was attributed to the advanced age of this patient group. It was observed that patients showing the greatest improvement in sexual function had also demonstrated marked or complete seizure relief. In comparison, other researchers have found no correlation between sexual dysfunction and seizure frequency or severity. 1, 3, 10, 20, 22, 27 Christianson et al. 27 observed no difference in post-operative sexual function even though 59% of patients experienced post-operative control of epileptic activity.
Epileptic discharge as a causative factor
Epileptic seizures have been linked to changes in autonomic nervous system function. During generalized tonic-clonic seizures, these changes are thought to be non-specific, while in partial seizures these discharges are thought to be discrete and specific. 28 Epileptiform discharges from the temporal lobe region may be transmitted through amygdala-hypothalamic pathways, disrupting the normal pulsatile secretion of gonadotropic hormones and the basal levels of dopamine secretion, resulting in hypogonadism and hyperprolactinemia. 29 Confirming this observation, Feeney et al. 30 reported acute cessation (between 1 and 16 weeks) of sexual behavior in four male cats after the induction of focal amygdala epileptiform activity by unilateral injection of aluminum hydroxide. Other investigators have supported the concept that temporal lobe epileptiform discharge has a modulating effect on neuroendocrine function, indicating that epileptiform discharges from the amygdala results in pulses of transient hyperprolactinemia 31 and selective lesions of the temporal lobe limbic complex cause hypogonadotropic hypogonadism and hyperprolactinemia. 29 
Hormonal issues and erectile dysfunction in epileptics
The center of control of the reproductive system resides in the nuclei of the medial basal hypothalamus. 32 Hypothalamic function is affected by several interrelated regulatory mechanisms, including hormonal feedback from gonadotropins and steroid hormones, as well as direct input from higher neurologic structures. In males, low levels of serum free testosterone results in the increased production of gonadotropin releasing hormone by the hypothalamic nuclei, resulting in the increased release of luteinizing hormone from the pituitary. Luteinizing hormone acts on the Leydig cells of the testes to both increase production of and release testosterone and dihydrotestosterone. 33 Testosterone exists in three distinct forms in the bloodstream: free (2-3%), albumin bound (53-55%), and sex hormone binding globulin bound (43-45%). 34 Free testosterone and the large constituent of albumin bound testosterone are available to tissues, constituting active testosterone, while the sex hormone binding globulin bound portion is unavailable to tissues and is not considered biologically active. 35 Hormonal changes resulting in the alteration of normal levels of biologically active testosterone may contribute to the sexual dysfunction observed in epileptic patients. 15, 29, 36, 37 Herzog et al. 15 assessed 20 men with TLE and found that of 11 (55%) of these patients had hyposexuality. Reproductive disorders were found in 9 of these 11 patients; 5 cases of hypogonadotropic hypogonadism, 2 cases of hyperprolactinemia, and 2 cases of hypergonadotropic hypogonadism. From a different perspective, Spark et al. 29 examined 16 men referred for hyposexuality. Eleven of these patients were diagnosed with TLE, while six were diagnosed with neuroendocrine abnormalities; four patients with low free testosterone and two patients with hyperprolactinemia. Their criteria for epilepsy diagnosis (sleep-deprived sleep EEG in addition to clinical symptoms sudden syncope, fugue states, vertigo, auditory hallucinations, recurrent abdominal pain, major motor seizures), has been questioned by others. 38, 39 While these criteria may be unconvincing for the proper diagnosis of epilepsy, this study is important because the patients who were naïve to antiepileptic drugs, illustrating the concept that epileptiform discharge itself may directly lead to alterations in neuroendocrine function resulting in sexual dysfunction.
Several changes in hormonal levels have been observed in epileptic patients. Serum prolactin has been reported to rise within 20 min in both generalized seizures or those induced with electroconvulsive therapy. 40 Increased prolactin levels have also been observed in two thirds of patients having seizures of frontal or temporal lobe origin. 41 In a recent review article by Lambert, 42 it was reported that most patients with generalized seizures, 41,43-45 and 39-100% of patients with complex partial seizures 31, 41, [45] [46] [47] have rises in serum prolactin, compared to less than 10% of patients with simple partial seizures. 41 Furthermore, it has been observed that complex partial seizures of frontal lobe origin were less likely to be associated with an elevation of serum prolactin than seizures of temporal lobe origin. 48 The existence of persistent reproductive endocrine abnormalities in men with epilepsy is also suggested by interictal findings of abnormal serum testosterone and gonadotropin concentrations, 15 and altered luteinizing hormone responses to gonadotropin releasing hormone stimulation. 49 In their sample of 37 epileptic men, Murialdo et al. 18 reported lower levels of free testosterone, DHT, and increased sex hormone binding globulin. A more recent study 37 examined 22 men with medically intractable epilepsy, both pre-and post-temporal lobe surgery. Fourteen of these patients became seizure free following surgery. In half of these seizure-free patients, total testosterone, free testosterone, and androstenedione increased, even though anticonvulsant medications were maintained. Patients who failed to become seizure-free postoperatively did not show significant alterations in hormonal levels. Patients with low total and free testosterone tend to have reduced nocturnal penile tumescence and diminished sexual activity, 50 and levels of DHT have been positively correlated with frequency of orgasm in healthy men. 51 Increases in serum estradiol have been described in epileptic patients as well, 18, 52 but in each of these studies the patients were currently receiving antiepileptic therapy. Although studies have documented changes in hormone levels in epileptic patients, it is important to also consider the role of antiepileptic pharmacotherapy as a causative factor.
Role of medication induced erectile dysfunction
There is plentiful evidence to suggest that antiepileptic drugs alter the serum concentrations of sex hormones and the regulatory feedback loop of the hypothalamic-pituitary-gonadal axis by a number of mechanisms. This is thought to contribute to the sexual dysfunction observed in epileptic patients who chronically receive antiepileptic medications. The extent of its role in sexual dysfunction versus that of psychosocial issues and the effects of epileptiform discharge is much less clear. There have been a number of studies examining epilepsy and alterations in hormonal levels, but in a vast majority of these studies the subjects were concurrently receiving antiepileptic drug therapy making it difficult to discern causality.
Conney 53 reported that phenytoin, phenobarbital, and testosterone are hydroxylated by a common hepatic microsomal enzyme system, increasing the metabolism and clearance of free testosterone and lowering the serum level of free testosterone. Decreased levels in urine 17-ketosteroid concentrations have been reported in patients receiving antiepileptic medications as well. 54, 55 It has also been proposed that the use of antiepileptic medications is associated with increased circulating levels of sex hormone binding globulin. 56 Barragry et al. 57 found that levels of serum testosterone and sex hormone binding globulin were elevated in treated epileptic male subjects. Researchers 15, 57, 58 theorized that despite normal pituitary and testicular regulatory function, increased hepatic synthesis and secretion of sex hormone binding globulin results in elevated serum total testosterone concentrations, yet decreases serum free testosterone. Toone et al. 59 confirmed the finding of lowered serum free testosterone in treated epileptic men, and found an association between lower free testosterone and higher serum gonadotropin levels.
In addition, phenytoin has been associated with an increase in estradiol concentrations, 18, 52 which raises the possibility that in addition to inducing the synthesis and secretion of sex hormone binding globulin, it may also induce aromatase, converting free testosterone to estradiol. 60 Although estradiol makes up approximately 1% of a male's total steroid sex hormones, it constitutes almost 50% of the negative feedback on male luteinizing hormone secretion. 61, 62 Thus, an increase in estradiol leading to suppression of luteinizing hormone secretion would result in a hypogonadotropic hypogonadism state. 35 Estradiol has also been associated with premature aging of the hypothalamic arcuate nucleus, 63, 64 which could also potentially lead to the development of hypogonadotropic hypogonadism. 65 Finally, estradiol increases the synthesis and secretion of sex hormone binding globulin 66 which would alter levels of free testosterone as described above. The resulting decreased levels of free testosterone would produce a critically low ratio of free testosterone to estradiol, which could clinically manifest itself as hyposexuality. 35 It is not plausible to consider anticonvulsant medication as the sole cause of sexual dysfunction in epileptic patients. Researchers studying patient populations naïve to antiepileptic medications have documented evidence of hyposexuality, thus disputing the role of antiepileptic medications in sexual dysfunction. Gastaut and Collomb 20 observed hyposexuality in two third of their patients, none of whom were receiving antiepileptic therapy. In another study, 15 patients with both TLE and erectile dysfunction were observed. 67 In three of these patients, the development of sexual dysfunction preceded the development of epilepsy by at least 6 months. During this time interval, these patients received no antiepileptic medical treatment. Bauer et al. 37 reported that sex hormone levels normalized in half of the patients who underwent successful epilepsy surgery, despite continued medical treatment. However, most studies implicate medical therapy as a contributing factor to sexual dysfunction in epileptics. Supporting this theory, Connel et al. 68 administered carbamazepine to a series of patients who did not have epilepsy, and found a rise in sex hormone binding globulin and decreases in total testosterone, free testosterone, and DHT within 7 days of starting the medication. However, within 3 weeks of continued therapy, hormonal levels normalized.
Diagnostic workup
There are several different etiologies in the pathogenesis of erectile dysfunction in patients with epilepsy. It is likely that epilepsy itself, antiepileptic drugs, and psychosocial factors all play a role. The initial evaluation of any patient with erectile dysfunction should include a full endocrine workup, psychological screening and evaluation, complete sexual and relationship history, medication history, and a nocturnal penile tumescence evaluation. Serum levels of free testosterone, estradiol, and prolactin should be obtained. A full screening for depression and anxiety disorders should be obtained. While this can be done in the office or outpatient setting, consultation with a psychologist may be warranted. At the same time, it is important to elicit a full sexual and relationship history. There are innumerable contributing factors to erectile dysfunction, and any evaluation would be incomplete without considering life stressors in its etiology. Finally, nocturnal penile tumescence should be evaluated. Diminished rigidity has been shown to be associated with inability to initiate and maintain penetration 69 and predicts the absence of spontaneous morning erections. 70 This can assist in the differentiation between organic and psychogenic erectile dysfunction. 71 Physiological erectile dysfunction should impair daytime and nocturnal erections equally. Finally, impaired tumescence is associated with vasogenic erectile dysfunction while impaired rigidity is associated with neurogenic erectile dysfunction. 50 Tumescence and rigidity can be measured by ambulatory units that are both cost efficient and more accurate than home devices. 72 
Treatment options
Once the etiology of sexual dysfunction has been determined, a proper treatment strategy may be implemented. For years the approach in treating patients with neuroendocrine dysfunction and TLE was to first treat the epilepsy with anticonvulsant medications and then, if hormone abnormalities and symptoms persisted, add supplemental hormonal therapy. In one study, four of five hyposexual patients with TLE were treated with anticonvulsant therapy alone and while seizure activity was controlled, hyposexuality persisted, requiring the use of parenteral testosterone or bromocriptine. 29 Daniels et al. 73 found that improvement in sexual functioning accompanied improved seizure control in a placebo-controlled study of intra-muscular testosterone. However, Herzog 35 reported that testosterone was only moderately effective in restoring reproductive and sexual function. He postulated that this was due to the induction of aromatase and the subsequent increase in estradiol levels and its effects on sexual function. Guldner and Morrell 72 reported that if erectile dysfunction appears to be physiologically mediated, it is important to examine pharmacologic therapy. Both improved seizure control and erectile response may be attained by changing antiepileptic medications or increasing non-barbituate antiepileptic medications. 67, 74 Rattya et al. 58 examined the effects of carbamazepine, oxcarbazepine, and valproate in epileptic men and found that carbamazepine is associated with a progressive increase in circulating levels of sex hormone binding globulin. This confirmed the results of prior studies. However, they found that oxcarbazepine, a keto-derivative of carbamazepine metabolized in the liver by reduction instead of oxidation, does not induce the oxidative p450 enzyme system to the same extent as carbamazepine, although these liver enzymes are progressively induced at higher doses. Thus, oxcarbazepine may be a more effective form of treatment in epileptic patients suffering from hyposexuality.
Symptomatic approaches to the treatment of erectile dysfunction can be implemented either in conjunction with the above treatment plans or if the above methods fail. These include physical stimulation of the penis to initiate spinal reflexes, placing an elastic constricting band at the base of the penis to prevent outflow of blood, and vacuum devices designed to create negative pressure facilitating cavernous blood flow. 72 There are more invasive techniques, including the intercavernosal injection of vasodilators, such as papaverine or a combination of papaverine, phentolamine, and prostaglandin E1, 75 or yohimbine. 76, 77 Additional methods of treatment include topical nitroglycerine, 78 topical minoxidil, 79 and sildenafil, which has been shown to improve the quality and frequency of erections, regardless of etiology while not effecting libido. 80 However, there are no studies involving the drug sildenafil in treatment of patients suffering from epilepsy.
Conclusion
Sexual dysfunction in epileptic patients appears to be multifactorial with no clearly defined solitary cause. Although many studies report the presence of hormonal changes and sexual disorders in epileptic patients, there are substantial differences in both patient populations and characterization of epilepsy and sexual disorders. Furthermore, a clear majority of these studies report hormonal changes attributable to epilepsy in patients who are concurrently receiving anticonvulsant pharmacologic therapy. Determining how prominent a role antiepileptic medication plays in the development of sexual dysfunction compared to hormonal changes appears to be the least explored aspect of this dilemma. However, it is almost impossible to study epileptic patients naïve to antiepileptic medical therapy due to ethical considerations. In order to more fully understand the etiology of sexual dysfunction in epileptics, more attention needs to be addressed in selecting patient populations. This can be attained by identifying patients with epilepsy using standardized diagnostic criteria, comparing reproductive hormonal levels of hyposexual epileptic men with their asymptomatic counterparts, comparing patients with similar and different loci of epileptiform discharge and finally characterizing specific reproductive endocrine disorders in epileptic men more diligently.
